GHO Capital appoints Olav König as Head of Investor Relations GHO Capital Updates GHO Capital appoints Olav König as Head of Investor Relations
Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies Biocare Medical Excellere Partners and GHO Capital complete sale of Biocare Medical to Agilent Technologies
GHO Capital and CBC Group to Create World’s Largest Dedicated Healthcare Investment Firm GHO Capital Updates GHO Capital and CBC Group to Create World’s Largest Dedicated Healthcare Investment Firm
Alcami to Acquire Contract Packaging Organization Tjoapack Alcami Alcami to Acquire Contract Packaging Organization Tjoapack
GHO Capital completes sale of VISUfarma to Lupin VISUfarma GHO Capital completes sale of VISUfarma to Lupin
GHO Capital and Excellere Partners Sell Biocare Medical to Agilent Technologies Biocare Medical GHO Capital and Excellere Partners Sell Biocare Medical to Agilent Technologies
GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare GHO Capital Updates GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare
IONTAS and FairJourney Biologics Discover SARS-CoV2 Neutralising Antibodies with Picomolar Potency FairJourney Biologics IONTAS and FairJourney Biologics Discover SARS-CoV2 Neutralising Antibodies with Picomolar Potency
GHO Capital acquires X-Chem, a leading drug discovery service provider X-Chem GHO Capital acquires X-Chem, a leading drug discovery service provider
FairJourney Biologics joins forces with Iontas to create a global leader in outsourced antibody discovery services FairJourney Biologics FairJourney Biologics joins forces with Iontas to create a global leader in outsourced antibody discovery services
Sterling Pharma Solutions commences the production of potential COVID-19 treatment Sterling Pharma Solutions Sterling Pharma Solutions commences the production of potential COVID-19 treatment
Leading global antibody discovery companies FairJourney Biologics and Iontas announce partnership in search for SARS-CoV-2 treatment FairJourney Biologics Leading global antibody discovery companies FairJourney Biologics and Iontas announce partnership in search for SARS-CoV-2 treatment
Envision Pharma announces acquisition of London-based behavioural science-led communications group 90TEN Envision Pharma Group Envision Pharma announces acquisition of London-based behavioural science-led communications group 90TEN
GHO Capital invests in FairJourney Biologics, a global leader in monoclonal antibody discovery services for biopharma FairJourney Biologics GHO Capital invests in FairJourney Biologics, a global leader in monoclonal antibody discovery services for biopharma
GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma. Ardena GHO Capital acquires Ardena, a leading CDMO providing early stage drug development and manufacturing for small-to-mid sized biopharma.
GHO Capital raises €975m in largest ever European healthcare fund GHO Capital Updates GHO Capital raises €975m in largest ever European healthcare fund
BioAgilytix announces acquisition of Boston-based clinical research organisation Cambridge Biomedical BioAgilytix BioAgilytix announces acquisition of Boston-based clinical research organisation Cambridge Biomedical
Validant acquires DataRevive, a regulatory strategy and consulting business focused on novel therapeutics and biologics ELIQUENT Life Sciences Validant acquires DataRevive, a regulatory strategy and consulting business focused on novel therapeutics and biologics
GHO Capital announces the sale of Caprion Biosciences Caprion Biosciences GHO Capital announces the sale of Caprion Biosciences
